Temat: "glioblastoma" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts.
Autorzy:: Yabo YA; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210, Luxembourg, Luxembourg.; Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, L-4367, Belvaux, Luxembourg.
Moreno-Sanchez PM; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210, Luxembourg, Luxembourg.; Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, L-4367, Belvaux, Luxembourg.
Pires-Afonso Y; Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, L-4367, Belvaux, Luxembourg.; Neuro-Immunology Group, Department of Cancer Research, Luxembourg Institute of Health, L-1210, Luxembourg, Luxembourg.
Kaoma T; Bioinformatics Platform, Department of Medical Informatics, Luxembourg Institute of Health, L-1445, Strassen, Luxembourg.
Nosirov B; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210, Luxembourg, Luxembourg.; Multiomics Data Science, Department of Cancer Research, Luxembourg Institute of Health, L-1445, Strassen, Luxembourg.
Scafidi A; Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, L-4367, Belvaux, Luxembourg.; Neuro-Immunology Group, Department of Cancer Research, Luxembourg Institute of Health, L-1210, Luxembourg, Luxembourg.
Ermini L; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210, Luxembourg, Luxembourg.
Lipsa A; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210, Luxembourg, Luxembourg.
Oudin A; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210, Luxembourg, Luxembourg.
Kyriakis D; Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, L-4367, Belvaux, Luxembourg.; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, L-4362, Esch-sur-Alzette, Luxembourg.
Grzyb K; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, L-4362, Esch-sur-Alzette, Luxembourg.
Poovathingal SK; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, L-4362, Esch-sur-Alzette, Luxembourg.; Single Cell Analytics & Microfluidics Core, Vlaams Instituut Voor Biotechnologie-KU Leuven, 3000, Louvain, Belgium.
Poli A; Neuro-Immunology Group, Department of Cancer Research, Luxembourg Institute of Health, L-1210, Luxembourg, Luxembourg.
Muller A; Bioinformatics Platform, Department of Medical Informatics, Luxembourg Institute of Health, L-1445, Strassen, Luxembourg.
Toth R; Bioinformatics Platform, Department of Medical Informatics, Luxembourg Institute of Health, L-1445, Strassen, Luxembourg.; Multiomics Data Science, Department of Cancer Research, Luxembourg Institute of Health, L-1445, Strassen, Luxembourg.
Klink B; National Center of Genetics, Laboratoire National de Santé, L-3555, Dudelange, Luxembourg.; Department of Cancer Research, Luxembourg Institute of Health, L-1210, Luxembourg, Luxembourg.; German Cancer Consortium (DKTK): Core Unit for Molecular Tumor Diagnostics (CMTD), National Center for Tumor Diseases (NCT/UCC), Cancer Consortium (DKTK) Partner Site Dresden, and German Cancer Research Center (DKFZ), Dresden, Heidelberg, 01307, Germany.; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.
Berchem G; Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, L-4367, Belvaux, Luxembourg.; Department of Cancer Research, Luxembourg Institute of Health, L-1210, Luxembourg, Luxembourg.; Centre Hospitalier Luxembourg, L-1210, Luxembourg, Luxembourg.
Berthold C; Centre Hospitalier Luxembourg, L-1210, Luxembourg, Luxembourg.
Hertel F; Centre Hospitalier Luxembourg, L-1210, Luxembourg, Luxembourg.
Mittelbronn M; Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, L-4367, Belvaux, Luxembourg.; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, L-4362, Esch-sur-Alzette, Luxembourg.; Department of Cancer Research, Luxembourg Institute of Health, L-1210, Luxembourg, Luxembourg.; Luxembourg Center of Neuropathology (LCNP), L-3555, Dudelange, Luxembourg.; National Center of Pathology (NCP), Laboratoire National de Santé, L-3555, Dudelange, Luxembourg.
Heiland DH; Translational Neurosurgery, Friedrich-Alexander University Erlangen Nuremberg, 91054, Erlangen, Germany.; Department of Neurosurgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen Nuremberg, 91054, Erlangen, Germany.; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.; Department of Neurosurgery, Medical Center, University of Freiburg, 79106, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, 79106, Freiburg, Germany.
Skupin A; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, L-4362, Esch-sur-Alzette, Luxembourg.; Department of Physics and Material Science, University Luxembourg, L-4367, Belvaux, Luxembourg.; Department of Neuroscience, University of California San Diego, La Jolla, CA, 92093, USA.
Nazarov PV; Bioinformatics Platform, Department of Medical Informatics, Luxembourg Institute of Health, L-1445, Strassen, Luxembourg.; Multiomics Data Science, Department of Cancer Research, Luxembourg Institute of Health, L-1445, Strassen, Luxembourg.
Niclou SP; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210, Luxembourg, Luxembourg.; Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, L-4367, Belvaux, Luxembourg.
Michelucci A; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210, Luxembourg, Luxembourg. .; Neuro-Immunology Group, Department of Cancer Research, Luxembourg Institute of Health, L-1210, Luxembourg, Luxembourg. .; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, L-4362, Esch-sur-Alzette, Luxembourg. .
Golebiewska A; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210, Luxembourg, Luxembourg. .; Pokaż więcej
Źródło:: Genome medicine [Genome Med] 2024 Apr 02; Vol. 16 (1), pp. 51. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/genetics
Glioblastoma*/metabolism
Brain Neoplasms*/genetics
Brain Neoplasms*/metabolism
Mice ; Animals ; Humans ; Microglia/metabolism ; Ecosystem ; Heterografts ; Phenotype ; Disease Models, Animal ; Dendritic Cells/metabolism ; Tumor Microenvironment/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Integrative multi-omics characterization reveals sex differences in glioblastoma.
Autorzy:: Jang B; Department of Biomedical Informatics, Korea University College of Medicine, Seoul, South Korea.; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea.
Yoon D; Department of Biomedical Informatics, Korea University College of Medicine, Seoul, South Korea.; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea.
Lee JY; Department of Biomedical Informatics, Korea University College of Medicine, Seoul, South Korea.; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea.
Kim J; Department of Biomedical Informatics, Korea University College of Medicine, Seoul, South Korea.; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea.
Hong J; Department of Biomedical Informatics, Korea University College of Medicine, Seoul, South Korea.; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea.
Koo H; Department of Biomedical Informatics, Korea University College of Medicine, Seoul, South Korea.; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea.; Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, South Korea.; Department of Clinical Research, Research Institute and Hospital, National Cancer Center, Goyang, South Korea.
Sa JK; Department of Biomedical Informatics, Korea University College of Medicine, Seoul, South Korea. .; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, South Korea. .; Pokaż więcej
Źródło:: Biology of sex differences [Biol Sex Differ] 2024 Mar 16; Vol. 15 (1), pp. 23. Date of Electronic Publication: 2024 Mar 16.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/genetics
Glioblastoma*/metabolism
Glioblastoma*/pathology
Brain Neoplasms*/genetics
Brain Neoplasms*/metabolism
Brain Neoplasms*/pathology
Adult ; Humans ; Male ; Female ; Proteomics ; Multiomics ; Sex Characteristics ; ErbB Receptors ; Genomic Instability ; Aneuploidy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: TGF-β-activated circRYK drives glioblastoma progression by increasing VLDLR mRNA expression and stability in a ceRNA- and RBP-dependent manner.
Autorzy:: Wang Y; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, 210000, China.
Wang B; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, 210000, China.
Cao W; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, 210000, China. .
Xu X; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, 210000, China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 08; Vol. 43 (1), pp. 73. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:: Journal Article
MeSH Terms:: MicroRNAs*/metabolism
Glioblastoma*/genetics
Glioblastoma*/metabolism
Humans ; Transforming Growth Factor beta/genetics ; Transforming Growth Factor beta/metabolism ; RNA, Competitive Endogenous ; RNA, Circular ; Cell Line, Tumor ; RNA, Messenger/genetics ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Cell Movement/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme.
Autorzy:: Meng J; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.
Qian W; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Department of Clinical Laborator, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, 215300, Suzhou, Jiangsu, China.
Yang Z; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.
Gong L; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.
Xu D; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.
Huang H; NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, 214063, Wuxi, China.
Jiang X; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China.
Pu Z; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China. .; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China. .
Yin Y; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China. .; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China. .
Zou J; Department of Laboratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China. .; Center of Clinical Research, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, 214023, Wuxi, Jiangsu, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 07; Vol. 24 (1), pp. 317. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article
MeSH Terms:: Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Brain Neoplasms*/pathology
Glioblastoma*/drug therapy
Glioblastoma*/genetics
Glioblastoma*/metabolism
Humans ; Antineoplastic Agents, Alkylating/pharmacology ; Antineoplastic Agents, Alkylating/therapeutic use ; Cell Line, Tumor ; Drug Resistance, Neoplasm/genetics ; E2F7 Transcription Factor/metabolism ; Prognosis ; Temozolomide/pharmacology ; Temozolomide/therapeutic use ; Tumor Suppressor Protein p53/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches.
Autorzy:: Lofiego MF; University of Siena, Siena, Italy.
Piazzini F; University of Siena, Siena, Italy.
Caruso FP; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy.; Department of Electrical Engineering and Information Technology (DIETI), University of Naples 'Federico II', Naples, Italy.
Marzani F; University of Siena, Siena, Italy.
Solmonese L; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.
Bello E; University of Siena, Siena, Italy.
Celesti F; University of Siena, Siena, Italy.
Costa MC; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy.; Department of Electrical Engineering and Information Technology (DIETI), University of Naples 'Federico II', Naples, Italy.
Noviello T; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy.; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA.; Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA.
Mortarini R; Human Tumors Immunobiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Anichini A; Human Tumors Immunobiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Ceccarelli M; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy.; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA.; Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA.
Coral S; University of Siena, Siena, Italy.
Di Giacomo AM; University of Siena, Siena, Italy.; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.
Maio M; University of Siena, Siena, Italy.; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.
Covre A; University of Siena, Siena, Italy. .; Pokaż więcej
Corporate Authors:: EPigenetic Immune-oncology Consortium Airc (EPICA) investigators
Źródło:: Journal of translational medicine [J Transl Med] 2024 Mar 01; Vol. 22 (1), pp. 223. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/genetics
Glioblastoma*/therapy
Glioblastoma*/metabolism
Azacitidine/*analogs & derivatives
Humans ; Azacitidine/therapeutic use ; Epigenesis, Genetic ; Immunotherapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Integrated transcriptomics uncovers an enhanced association between the prion protein gene expression and vesicle dynamics signatures in glioblastomas.
Autorzy:: Boccacino JM; Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1524 room 431, Sao Paulo, 05508000, Brazil.
Dos Santos Peixoto R; Department of Automation and Systems, Technological Center, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil.
Fernandes CFL; Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1524 room 431, Sao Paulo, 05508000, Brazil.
Cangiano G; Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1524 room 431, Sao Paulo, 05508000, Brazil.
Sola PR; Cellular and Molecular Biology Laboratory (LIM 15), Department of Neurology, Faculdade de Medicina (FMUSP), University of Sao Paulo, Sao Paulo, Brazil.
Coelho BP; Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1524 room 431, Sao Paulo, 05508000, Brazil.
Prado MB; Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1524 room 431, Sao Paulo, 05508000, Brazil.
Melo-Escobar MI; Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1524 room 431, Sao Paulo, 05508000, Brazil.
de Sousa BP; Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1524 room 431, Sao Paulo, 05508000, Brazil.
Ayyadhury S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; The Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
Bader GD; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; The Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.; Department of Computer Science, University of Toronto, Toronto, Ontario, Canada.
Shinjo SMO; Cellular and Molecular Biology Laboratory (LIM 15), Department of Neurology, Faculdade de Medicina (FMUSP), University of Sao Paulo, Sao Paulo, Brazil.
Marie SKN; Cellular and Molecular Biology Laboratory (LIM 15), Department of Neurology, Faculdade de Medicina (FMUSP), University of Sao Paulo, Sao Paulo, Brazil.
da Rocha EL; Department of Microbiology, Immunology, and Parasitology, Biological Sciences Center, Federal University of Santa Catarina, Florianópolis, Santa Catarina, 88040-900, Brazil. .
Lopes MH; Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1524 room 431, Sao Paulo, 05508000, Brazil. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Feb 13; Vol. 24 (1), pp. 199. Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/genetics
Glioblastoma*/pathology
Prions*/genetics
Prions*/metabolism
Humans ; Gene Expression ; Gene Expression Profiling ; Prion Proteins/genetics ; Prion Proteins/metabolism ; rab GTP-Binding Proteins/genetics ; Synaptophysin/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Long noncoding RNA UNC5B-AS1 suppresses cell proliferation by sponging miR-24-3p in glioblastoma multiforme.
Autorzy:: Song Y; Department of Neurology, Peking University Shenzhen Hospital, Shenzhen, 518036, China.
Chen B; Department of Neurosurgery, Peking University Shenzhen Hospital, Shenzhen, 518036, China.
Jiao H; Department of Neurology, Peking University Shenzhen Hospital, Shenzhen, 518036, China.
Yi L; Department of Neurology, Peking University Shenzhen Hospital, Shenzhen, 518036, China. .; Pokaż więcej
Źródło:: BMC medical genomics [BMC Med Genomics] 2024 Apr 09; Vol. 17 (1), pp. 83. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/pathology
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
MicroRNAs*/genetics
MicroRNAs*/metabolism
Humans ; Prospective Studies ; Cell Line, Tumor ; Cell Proliferation/genetics ; Cell Movement/genetics ; Gene Expression Regulation, Neoplastic ; Netrin Receptors/genetics ; Netrin Receptors/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Tumor associated microglia/macrophages utilize GPNMB to promote tumor growth and alter immune cell infiltration in glioma.
Autorzy:: Yalcin F; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Institute of Pathology, Christian-Albrecht University of Kiel, Kiel, Germany.; Department of Neurosurgery, University Medical Center Schleswig-Holstein, Kiel, Germany.
Haneke H; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Efe IE; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Charité Universitätsmedizin Berlin, Berlin, Germany.
Kuhrt LD; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Charité Universitätsmedizin Berlin, Berlin, Germany.
Motta E; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Nickl B; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Flüh C; Department of Neurosurgery, University Medical Center Schleswig-Holstein, Kiel, Germany.
Synowitz M; Department of Neurosurgery, University Medical Center Schleswig-Holstein, Kiel, Germany.
Dzaye O; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, USA.
Bader M; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; DZHK (German Center for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.; Charité Universitätsmedizin Berlin, Berlin, Germany.; Institute for Biology, University of Lübeck, Lübeck, Germany.
Kettenmann H; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany. .; Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China. .; Pokaż więcej
Źródło:: Acta neuropathologica communications [Acta Neuropathol Commun] 2024 Apr 02; Vol. 12 (1), pp. 50. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article
MeSH Terms:: Brain Neoplasms*/pathology
Glioblastoma*/pathology
Glioma*/pathology
Animals ; Humans ; Mice ; Cell Line, Tumor ; Macrophages/metabolism ; Membrane Glycoproteins/metabolism ; Microglia/metabolism ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM].
Autorzy:: Gibson D; Department of Neuro-Oncology, University of California, San Francisco, 400 Parnassus Ave, San Francisco, CA, USA.; Department of Bioinformatics, University of California, Los Angeles, Los Angeles, CA, USA.
Vo AH; Department of Neuro-Oncology, University of California, San Francisco, 400 Parnassus Ave, San Francisco, CA, USA. .
Lambing H; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.; Department of Human Genetics, University of California, Los Angeles, Los Angeles, CA, USA.
Bhattacharya P; Department of Neuro-Oncology, University of California, San Francisco, 400 Parnassus Ave, San Francisco, CA, USA.
Tahir P; University of California, San Francisco Library, San Francisco, CA, USA.
Chehab FF; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.
Butowski N; Department of Neuro-Oncology, University of California, San Francisco, 400 Parnassus Ave, San Francisco, CA, USA.; Pokaż więcej
Źródło:: BMC neurology [BMC Neurol] 2024 Mar 23; Vol. 24 (1), pp. 103. Date of Electronic Publication: 2024 Mar 23.
Typ publikacji:: Systematic Review; Journal Article
MeSH Terms:: Glioblastoma*/genetics
Brain Neoplasms*/genetics
Glioma*/genetics
Adult ; Humans ; DNA Methylation/genetics ; Prognosis ; Antineoplastic Agents, Alkylating ; DNA Modification Methylases/genetics ; Tumor Suppressor Proteins/genetics ; DNA Repair Enzymes/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: CD13 expression affects glioma patient survival and influences key functions of human glioblastoma cell lines in vitro.
Autorzy:: Zhang W; Department of Experimental Neurosurgery, Charité- Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Blank A; Department of Experimental Neurosurgery, Charité- Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Kremenetskaia I; Department of Experimental Neurosurgery, Charité- Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Nitzsche A; Department of Experimental Neurosurgery, Charité- Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Acker G; Department of Experimental Neurosurgery, Charité- Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.; Department of Neurosurgery, Charité- Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.; Berlin Institute of Health at Charité, Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Vajkoczy P; Department of Experimental Neurosurgery, Charité- Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany. .; Department of Neurosurgery, Charité- Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany. .
Brandenburg S; Department of Experimental Neurosurgery, Charité- Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 22; Vol. 24 (1), pp. 369. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/genetics
Glioma*/genetics
Humans ; Apoptosis ; CD13 Antigens/genetics ; CD13 Antigens/metabolism ; Cell Line, Tumor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.
Autorzy:: Saeed AM; Department of Radiation Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, USA.; Maryland Proton Treatment Center, Baltimore, MD, USA.
Bentzen SM; Department of Radiation Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, USA.; Department of Epidemiology and Public Health, Division of Biostatistics and Bioinformatics, University of Maryland School of Medicine, Baltimore, USA.
Ahmad H; Department of Medical Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, USA.
Pham L; Department of Medical Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, USA.
Woodworth GF; Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Mishra MV; Department of Radiation Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, USA. .; Maryland Proton Treatment Center, Baltimore, MD, USA. .; Pokaż więcej
Źródło:: Radiation oncology (London, England) [Radiat Oncol] 2024 Mar 14; Vol. 19 (1), pp. 36. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:: Systematic Review; Journal Article
MeSH Terms:: Glioblastoma*
Brain Neoplasms*/radiotherapy
Lymphopenia*/etiology
Humans ; Temozolomide/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: DNA hypomethylator phenotype reprograms glutamatergic network in receptor tyrosine kinase gene-mutated glioblastoma.
Autorzy:: Harachi M; Department of Pathology, Tokyo Women's Medical University, Shinjuku, Tokyo, 162-8666, Japan.; Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, 230-0045, Japan.
Masui K; Department of Pathology, Tokyo Women's Medical University, Shinjuku, Tokyo, 162-8666, Japan. .
Shimizu E; Department of Pathology, Tokyo Women's Medical University, Shinjuku, Tokyo, 162-8666, Japan.
Murakami K; Department of Pathology, Tokyo Women's Medical University, Shinjuku, Tokyo, 162-8666, Japan.
Onizuka H; Department of Pathology, Tokyo Women's Medical University, Shinjuku, Tokyo, 162-8666, Japan.
Muragaki Y; Department of Neurosurgery, Tokyo Women's Medical University, Shinjuku, Tokyo, 162-8666, Japan.; Center for Advanced Medical Engineering Research and Development, Kobe University, Kobe, Hyogo, 650-0047, Japan.
Kawamata T; Department of Neurosurgery, Tokyo Women's Medical University, Shinjuku, Tokyo, 162-8666, Japan.
Nakayama H; Department of Physiology, Tokyo Women's Medical University, Shinjuku, Tokyo, 162-8666, Japan.
Miyata M; Department of Physiology, Tokyo Women's Medical University, Shinjuku, Tokyo, 162-8666, Japan.
Komori T; Department of Neuropathology, Tokyo Metropolitan Neurological Hospital, Musashinodai, Tokyo, 156-8506, Japan.
Cavenee WK; Ludwig Institute for Cancer Research, University of California San Diego, La Jolla, CA, 92093, USA.
Mischel PS; Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Kurata A; Department of Pathology, Tokyo Women's Medical University, Shinjuku, Tokyo, 162-8666, Japan.
Shibata N; Department of Pathology, Tokyo Women's Medical University, Shinjuku, Tokyo, 162-8666, Japan.; Pokaż więcej
Źródło:: Acta neuropathologica communications [Acta Neuropathol Commun] 2024 Mar 13; Vol. 12 (1), pp. 40. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/pathology
Brain Neoplasms*/pathology
Mice ; Animals ; Cell Line, Tumor ; Mechanistic Target of Rapamycin Complex 2/genetics ; Mechanistic Target of Rapamycin Complex 2/metabolism ; DNA Methylation ; Phenotype ; DNA/metabolism ; Methyltransferases/genetics ; Methyltransferases/metabolism ; Protein-Tyrosine Kinases/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche.
Autorzy:: de Oliveira KG; Department of Clinical Sciences, Lund, Section of Oncology, Lund University, Barngatan 4, 221 85, Lund, Sweden.
Bång-Rudenstam A; Department of Clinical Sciences, Lund, Section of Oncology, Lund University, Barngatan 4, 221 85, Lund, Sweden.
Beyer S; Department of Clinical Sciences, Lund, Section of Oncology, Lund University, Barngatan 4, 221 85, Lund, Sweden.
Boukredine A; Department of Clinical Sciences, Lund, Section of Oncology, Lund University, Barngatan 4, 221 85, Lund, Sweden.
Talbot H; Department of Clinical Sciences, Lund, Section of Oncology, Lund University, Barngatan 4, 221 85, Lund, Sweden.
Governa V; Department of Clinical Sciences, Lund, Section of Oncology, Lund University, Barngatan 4, 221 85, Lund, Sweden.
Johansson MC; Department of Clinical Sciences, Lund, Section of Oncology, Lund University, Barngatan 4, 221 85, Lund, Sweden.
Månsson AS; Department of Clinical Sciences, Lund, Section of Oncology, Lund University, Barngatan 4, 221 85, Lund, Sweden.
Forsberg-Nilsson K; Department of Immunology, Genetics and Pathology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Division of Cancer and Stem Cells, University of Nottingham Biodiscovery Institute, Nottingham, UK.
Bengzon J; Department of Clinical Sciences, Section of Neurosurgery, Lund University, Lund, Sweden.
Malmström J; Department of Clinical Sciences, Division of Infection Medicine, Lund University, Lund, Sweden.
Welinder C; Department of Clinical Sciences, Lund, Section of Oncology, Lund University, Barngatan 4, 221 85, Lund, Sweden.
Belting M; Department of Clinical Sciences, Lund, Section of Oncology, Lund University, Barngatan 4, 221 85, Lund, Sweden. .; Department of Hematology, Oncology and Radiophysics, Skåne University Hospital, Lund, Sweden. .; Pokaż więcej
Źródło:: Acta neuropathologica communications [Acta Neuropathol Commun] 2024 Feb 27; Vol. 12 (1), pp. 35. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/pathology
Brain Neoplasms*/pathology
Adult ; Humans ; Hypoxia/metabolism ; Cell Line, Tumor ; Gene Expression Profiling ; Membrane Proteins ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Hypoxic glioblastoma-cell-derived extracellular vesicles impair cGAS-STING activity in macrophages.
Autorzy:: Tankov S; Translational Research Center in Onco-Hematology (CRTOH), Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Léman, Geneva and Lausanne, Switzerland.
Petrovic M; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
Lecoultre M; Translational Research Center in Onco-Hematology (CRTOH), Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Léman, Geneva and Lausanne, Switzerland.
Espinoza F; Translational Research Center in Onco-Hematology (CRTOH), Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Léman, Geneva and Lausanne, Switzerland.
El-Harane N; Translational Research Center in Onco-Hematology (CRTOH), Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Léman, Geneva and Lausanne, Switzerland.
Bes V; Translational Research Center in Onco-Hematology (CRTOH), Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Léman, Geneva and Lausanne, Switzerland.
Chliate S; Translational Research Center in Onco-Hematology (CRTOH), Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Léman, Geneva and Lausanne, Switzerland.
Bedoya DM; Translational Research Center in Onco-Hematology (CRTOH), Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Léman, Geneva and Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.
Jordan O; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
Borchard G; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
Migliorini D; Translational Research Center in Onco-Hematology (CRTOH), Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Léman, Geneva and Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.
Dutoit V; Translational Research Center in Onco-Hematology (CRTOH), Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Léman, Geneva and Lausanne, Switzerland.
Walker PR; Translational Research Center in Onco-Hematology (CRTOH), Faculty of Medicine, University of Geneva, Geneva, Switzerland. .; Swiss Cancer Center Léman, Geneva and Lausanne, Switzerland. .; Pokaż więcej
Źródło:: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Feb 22; Vol. 22 (1), pp. 144. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Extracellular Vesicles*/metabolism
Glioblastoma*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Animals ; Humans ; Mice ; Cryoelectron Microscopy ; Hypoxia/metabolism ; Macrophages/metabolism ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells.
Autorzy:: Victorio CBL; Laboratory for Translational and Molecular Imaging, Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Singapore, 169857. .
Novera W; Laboratory for Translational and Molecular Imaging, Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Singapore, 169857.
Ganasarajah A; Laboratory for Translational and Molecular Imaging, Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Singapore, 169857.
Ong J; Laboratory for Translational and Molecular Imaging, Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Singapore, 169857.
Thomas M; Laboratory for Translational and Molecular Imaging, Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Singapore, 169857.
Wu J; Laboratory for Translational and Molecular Imaging, Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Singapore, 169857.
Toh HSY; Laboratory of Human Neural Models, Neuroscience and Behavioural Disorders Programme, Duke-NUS Medical School, Singapore, Singapore, 169857.
Sun AX; Laboratory of Human Neural Models, Neuroscience and Behavioural Disorders Programme, Duke-NUS Medical School, Singapore, Singapore, 169857.
Ooi EE; Programme in Emerging Infectious Disease, Duke-NUS Medical School, Singapore, Singapore, 169857.
Chacko AM; Laboratory for Translational and Molecular Imaging, Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Singapore, 169857. .; Division of Cellular and Molecular Research, National Cancer Centre, Singapore, Singapore, 169610. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Feb 02; Vol. 22 (1), pp. 126. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:: Journal Article
MeSH Terms:: Zika Virus*/physiology
Oncolytic Viruses*
Zika Virus Infection*/prevention & control
Glioblastoma*/therapy
Oncolytic Virotherapy*
Humans ; Vaccines, Attenuated ; Neoplasm Recurrence, Local/therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor NONO.
Autorzy:: Chen Y; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang, P. R. China.; Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, 310000, Zhejiang, P. R. China.
Xu X; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang, P. R. China.; Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, 310000, Zhejiang, P. R. China.
Ding K; Department of Radiation Oncology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang, P. R. China.
Tang T; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang, P. R. China.; Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, 310000, Zhejiang, P. R. China.
Cai F; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang, P. R. China.; Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, 310000, Zhejiang, P. R. China.
Zhang H; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang, P. R. China.; Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, 310000, Zhejiang, P. R. China.
Chen Z; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang, P. R. China.; Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, 310000, Zhejiang, P. R. China.
Qi Y; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang, P. R. China.; Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, 310000, Zhejiang, P. R. China.
Fu Z; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang, P. R. China.; Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, 310000, Zhejiang, P. R. China.
Zhu G; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang, P. R. China.; Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, 310000, Zhejiang, P. R. China.
Dou Z; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang, P. R. China.; Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, 310000, Zhejiang, P. R. China.
Xu J; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang, P. R. China.; Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, 310000, Zhejiang, P. R. China.
Chen G; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang, P. R. China.; Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, 310000, Zhejiang, P. R. China.
Wu Q; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang, P. R. China. .; Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, 310000, Zhejiang, P. R. China. .
Ji J; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang, P. R. China. .; Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, 310000, Zhejiang, P. R. China. .
Zhang J; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang, P. R. China. .; Key Laboratory of Precise Treatment and Clinical Translational Research of Neurological Diseases, Hangzhou, 310000, Zhejiang, P. R. China. .; Brain Research Institute, Zhejiang University, Hangzhou, 310000, Zhejiang, P. R. China. .; MOE Frontier Science Center for Brain Science & Brain-Machine Integration Zhejiang University, Hangzhou, 310000, Zhejiang, P. R. China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Feb 02; Vol. 43 (1), pp. 39. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/metabolism
Glioblastoma*/pathology
Transcription Factors*/genetics
Transcription Factors*/metabolism
Tripartite Motif Proteins*
Humans ; Cell Line, Tumor ; Cell Proliferation ; DNA-Binding Proteins/genetics ; Gene Expression Regulation, Neoplastic ; Protein-Arginine N-Methyltransferases/genetics ; Protein-Arginine N-Methyltransferases/metabolism ; Repressor Proteins/metabolism ; RNA Splicing Factors/metabolism ; RNA-Binding Proteins/genetics ; RNA-Binding Proteins/metabolism ; Ubiquitin-Protein Ligases/genetics ; Ubiquitin-Protein Ligases/metabolism ; Ubiquitination

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Chronic hypoxia remodels the tumor microenvironment to support glioma stem cell growth.
Autorzy:: Nicholson JG; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Cirigliano S; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Singhania R; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Haywood C; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Shahidi Dadras M; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Yoshimura M; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Vanderbilt D; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Liechty B; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY, USA.
Fine HA; Department of Neurology, Weill Cornell Medicine, New York, NY, USA. .; Pokaż więcej
Źródło:: Acta neuropathologica communications [Acta Neuropathol Commun] 2024 Mar 25; Vol. 12 (1), pp. 46. Date of Electronic Publication: 2024 Mar 25.
Typ publikacji:: Journal Article
MeSH Terms:: Brain Neoplasms*/pathology
Glioma*/pathology
Glioblastoma*/pathology
Humans ; Tumor Microenvironment ; Ligands ; Neoplastic Stem Cells/metabolism ; Hypoxia/metabolism ; Cell Line, Tumor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Development of preoperative and postoperative models to predict recurrence in postoperative glioma patients: a longitudinal cohort study.
Autorzy:: Qiao W; Department of Biostatistics, School of Public Health & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Wang Y; Department of Tumor Screening and Prevention, Zhongshan Hospital, Fudan University, Shanghai, China.
Luo C; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; Neurosurgical Institute, Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.; Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China.
Wu J; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; Neurosurgical Institute, Fudan University, Shanghai, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.; Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China.
Qin G; Department of Biostatistics, School of Public Health & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.; Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
Zhang J; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. .; Neurosurgical Institute, Fudan University, Shanghai, China. .; Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China. .; Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China. .
Yao Y; Department of Biostatistics, School of Public Health & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China. .; National Clinical Research Centre for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China. .; Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Feb 28; Vol. 24 (1), pp. 274. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/complications
Glioma*/pathology
Brain Neoplasms*/pathology
Humans ; Longitudinal Studies ; Cohort Studies ; Proportional Hazards Models ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review.
Autorzy:: Regmi M; Department of Neurosurgery, Peking University Third Hospital, Peking University, Beijing, 100191, China.; Center for Precision Neurosurgery and Oncology of Peking University Health Science Center, Peking University, Beijing, 100191, China.; Peking University Health Science Center, Beijing, 100191, China.; Henan Academy of Innovations in Medical Science (AIMS), Zhengzhou, 450003, China.
Wang Y; Department of Neurosurgery, Peking University Third Hospital, Peking University, Beijing, 100191, China.; Center for Precision Neurosurgery and Oncology of Peking University Health Science Center, Peking University, Beijing, 100191, China.
Liu W; Department of Neurosurgery, Peking University Third Hospital, Peking University, Beijing, 100191, China.; Center for Precision Neurosurgery and Oncology of Peking University Health Science Center, Peking University, Beijing, 100191, China.; Peking University Health Science Center, Beijing, 100191, China.
Dai Y; Department of Neurosurgery, Peking University Third Hospital, Peking University, Beijing, 100191, China.; Center for Precision Neurosurgery and Oncology of Peking University Health Science Center, Peking University, Beijing, 100191, China.; Peking University Health Science Center, Beijing, 100191, China.
Liu S; Department of Neurosurgery, Peking University Third Hospital, Peking University, Beijing, 100191, China.; Center for Precision Neurosurgery and Oncology of Peking University Health Science Center, Peking University, Beijing, 100191, China.; Peking University Health Science Center, Beijing, 100191, China.
Ma K; Peking University Health Science Center, Beijing, 100191, China.
Lin G; Department of Neurosurgery, Peking University Third Hospital, Peking University, Beijing, 100191, China.; Center for Precision Neurosurgery and Oncology of Peking University Health Science Center, Peking University, Beijing, 100191, China.
Yang J; Department of Neurosurgery, Peking University Third Hospital, Peking University, Beijing, 100191, China.; Center for Precision Neurosurgery and Oncology of Peking University Health Science Center, Peking University, Beijing, 100191, China.
Liu H; Henan Academy of Innovations in Medical Science (AIMS), Zhengzhou, 450003, China.; National Engineering Research Center for Ophthalmology, Beijing, 100730, China.; Engineering Research Center of Ophthalmic Equipment and Materials, Ministry of Education, Beijing, 100730, China.; Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing, 100730, China.
Wu J; Henan Academy of Innovations in Medical Science (AIMS), Zhengzhou, 450003, China. .; National Engineering Research Center for Ophthalmology, Beijing, 100730, China. .; Engineering Research Center of Ophthalmic Equipment and Materials, Ministry of Education, Beijing, 100730, China. .; Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing, 100730, China. .
Yang C; Department of Neurosurgery, Peking University Third Hospital, Peking University, Beijing, 100191, China. .; Center for Precision Neurosurgery and Oncology of Peking University Health Science Center, Peking University, Beijing, 100191, China. .; Henan Academy of Innovations in Medical Science (AIMS), Zhengzhou, 450003, China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Feb 12; Vol. 43 (1), pp. 47. Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Glioma*/pathology
Glioblastoma*/pathology
Myeloid-Derived Suppressor Cells*
Brain Neoplasms*/drug therapy
Humans ; Immunotherapy ; Immunomodulation ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Combining a noble gas with radiotherapy: glutamate receptor antagonist xenon may act as a radiosensitizer in glioblastoma.
Autorzy:: Büttner T; Department of Radiation Oncology, Medical Faculty Mannheim, University Medical Centre Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. .; Clinic for Urology and Paediatric Urology, University Hospital Bonn, Venusberg Campus 1, 53127, Bonn, Germany. .
Maerevoet MKE; Department of Radiation Oncology, Medical Faculty Mannheim, University Medical Centre Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Giordano FA; Department of Radiation Oncology, Medical Faculty Mannheim, University Medical Centre Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Veldwijk MR; Department of Radiation Oncology, Medical Faculty Mannheim, University Medical Centre Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Herskind C; Department of Radiation Oncology, Medical Faculty Mannheim, University Medical Centre Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Ruder AM; Department of Radiation Oncology, Medical Faculty Mannheim, University Medical Centre Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.; Pokaż więcej
Źródło:: Radiation oncology (London, England) [Radiat Oncol] 2024 Jan 30; Vol. 19 (1), pp. 16. Date of Electronic Publication: 2024 Jan 30.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/radiotherapy
Glioblastoma*/metabolism
Radiation-Sensitizing Agents*/pharmacology
Humans ; Xenon/pharmacology ; Xenon/metabolism ; Excitatory Amino Acid Antagonists/pharmacology ; Memantine ; HeLa Cells ; Receptors, N-Methyl-D-Aspartate

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""glioblastoma"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Publikacja

Język

Rok publikacji